Our purpose was to compile information on the haematological manifestations of systemic
lupus erythematosus (SLE), namely leucopenia, lymphopenia, thrombocytopenia …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can involve any
organ system, and may lead to significant morbidity and even mortality. This article reviews …

Objective B cells are likely to contribute to the pathogenesis of systemic lupus
erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III …

An estimated 10% to 20% of patients experience the onset of systemic lupus erythematosus
(SLE) before adulthood. More precise estimates are difficult due to a lack of a clear age limit …

Lupus is a chronic, autoimmune multisystem inflam-matory disease that is associated with
sizable morbidity and mortality. 1 When lupus commences in an individual less than 18 …

Background Autoimmune haemolytic anaemia is a decompensated acquired haemolysis
caused by the host's immune system acting against its own red cell antigens. The incidence …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease and occurs
worldwide in both children and adults. The estimated annual incidence among children is …

Autoimmune hemolytic anemia (AIHA) is defined as a condition associated with the
increased destruction of red blood cells (RBCs) associated with the presence of IgG anti …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …